The Molecular Pharmaceutics & Drug Delivery Seminar Series Presents:
Dr. Calvin Sun, Professor & Associate Department Head, Department of Pharmaceutics, University of Minnesota
Cocrystallization – A versatile tool for improving pharmaceutical properties of drugs
Tuesday, March 5, 2024
11:00 a.m. – 12:00 p.m.
Virtual via Zoom
Relevant papers are available.
Dr. Sun is Professor of Pharmaceutics and Associate Department Head in the Department of Pharmaceutics, University of Minnesota, USA. Dr. Sun’s research focuses on formulation development of tablet products through appropriate application of materials science and engineering principles. Two areas of current research are 1) crystal and particle engineering for superior pharmaceutical properties and 2) fundamental understanding of pharmaceutical processes. As of February 2024, he had published 247 peer-reviewed papers in these areas with more than 13,800 citations (H-index = 64, Google Scholar profile).
His research impact in the past 5 years ranks #1 in the US by ScholarGPS. Dr. Sun currently serves on the editorial boards of CrystEngComm and Frontiers in Chemistry. He also serves on the editorial advisory boards of Int. J. Pharm., J. Pharm. Sci., Mol. Pharmaceutics, AAPS Open, and Pharm. Res. He has served on the Expert Committee in Physical Analysis of the United States Pharmacopeia since 2010. Dr. Sun is a Fellow of the American Association of Pharmaceutical Scientists (AAPS), the Royal Society of Chemistry (RSC), and the American Association for the Advancement of Science (AAAS). He received the 2019 Ralph Shangraw Memorial Award from the International Pharmaceutical Excipient Council (IPEC) and the 2022 David J. W. Grant NIPTE Distinguished Scholar Award in Basic Pharmaceutics.